Capricor Therapeutics (CAPR) Current Assets (2010 - 2026)
Capricor Therapeutics (CAPR) posted quarterly Current Assets of $283.1 million for Q1 2026, up 93.56% year-over-year from $146.3 million in Q1 2025, and down 12.34% quarter-over-quarter from $322.9 million in Q4 2025.
Capricor Therapeutics (CAPR) Current Assets (2010 - 2026) Analysis & Trends
Capricor Therapeutics' Current Assets history runs 17 years deep, the most recent figure standing at $283.1 million for Q1 2026.
- In Q1 2026, Current Assets rose 93.56% year-over-year to $283.1 million; the TTM figure through Mar 2026 stood at $283.1 million (up 93.56% YoY), while the FY2025 annual figure was $322.9 million, up 97.66% from the prior year.
- Current Assets for Q1 2026 stood at $283.1 million, down from $322.9 million in the prior quarter.
- The five-year high for Current Assets was $322.9 million in Q4 2025, with the low at $29.5 million in Q3 2023.
- The 5-year median for Current Assets is $52.6 million (2022), against an average of $98.1 million.
- The sharpest annual moves came in 2023 and 2025: Current Assets tumbled 37.84% in 2023, then jumped 304.73% in 2025.
- Capricor Therapeutics' Current Assets stood at $42.9 million in 2022, then gained by 18.58% to $50.9 million in 2023, then jumped by 221.27% to $163.4 million in 2024, then soared by 97.66% to $322.9 million in 2025, then retreated by 12.34% to $283.1 million in 2026.
- Business Quant data shows CAPR's Current Assets at $283.1 million in Q1 2026, $322.9 million in Q4 2025, and $101.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Capricor Therapeutics | 383.47 Mn | 383.47 Mn | - | 283.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 283.09 Mn |
| Dec 31, 2025 | 322.94 Mn |
| Sep 30, 2025 | 100.95 Mn |
| Jun 30, 2025 | 124.13 Mn |
| Mar 31, 2025 | 146.25 Mn |
| Dec 31, 2024 | 163.39 Mn |
| Sep 30, 2024 | 85.82 Mn |
| Jun 30, 2024 | 30.67 Mn |
| Mar 31, 2024 | 41.41 Mn |
| Dec 31, 2023 | 50.86 Mn |
| Sep 30, 2023 | 29.53 Mn |
| Jun 30, 2023 | 38.92 Mn |
| Mar 31, 2023 | 46.59 Mn |
| Dec 31, 2022 | 42.89 Mn |
| Sep 30, 2022 | 47.50 Mn |
| Jun 30, 2022 | 52.62 Mn |
| Mar 31, 2022 | 59.63 Mn |
| Dec 31, 2021 | 36.44 Mn |
| Sep 30, 2021 | 41.30 Mn |
| Jun 30, 2021 | 38.73 Mn |